DJ, M., A, F., G, W., CW, H., T, W., E, L., & C, S. (2026). Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients. CPT: pharmacometrics & systems pharmacology, 15(7), e70291. https://doi.org/10.1002/psp4.70291
Chicago Style (17th ed.) CitationDJ, Mulford, Facius A, Witt G, Howden CW, Wagner T, Leifke E, and Scarpignato C. "Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients." CPT: Pharmacometrics & Systems Pharmacology 15, no. 7 (2026): e70291. https://doi.org/10.1002/psp4.70291.
MLA (9th ed.) CitationDJ, Mulford, et al. "Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients." CPT: Pharmacometrics & Systems Pharmacology, vol. 15, no. 7, 2026, p. e70291, https://doi.org/10.1002/psp4.70291.